G

Galapagos NV
GLPG

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€1.51B
EV
€-1.77B
Shares Outstanding
65.90M
Beta
-0.01

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
€32.04
P/E 2025E
-
P/Revenue 2025E
5.52x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Galapagos NV

gainify

G

Galapagos NV

GLPG

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manuf...

Sector

Healthcare

Industry

Biotechnology

CEO

Stoffels, Paulus

Employees

704

IPO Date

2005-05-06

Headquarters

Generaal De Wittelaan L11 A3, Mechelen, Antwerp, 2800, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved